Brian Powl - Jan 28, 2025 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Role
Chief Commercial Officer
Signature
Teresa Bair, Attorney-in-fact for Brian Powl
Stock symbol
KURA
Transactions as of
Jan 28, 2025
Transactions value $
-$12,461
Form type
4
Date filed
1/28/2025, 08:38 PM
Previous filing
Jan 6, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KURA Common Stock Sale -$12.5K -1.58K -2.58% $7.87 59.7K Jan 28, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/24.